ImmunoCellular Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ImmunoCellular Therapeutics is scheduled to report earnings on August 13, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 18	Mar 18	Dec 17	Sep 17	Jun 17
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -307.09K	$ -1.02M	$ -431.30K	$ -3.90M	$ -3.62M
EBITDA	$ -306.98K	$ -1.02M	$ -430.66K	$ -3.89M	$ -3.61M
Net Income Common Stockholders	$ -306.70K	$ -1.02M	$ -1.62M	$ -6.08M	$ -4.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.85M	$ 5.03M	$ 6.63M	$ 6.01M	$ 1.81M
Total Assets	$ 3.83M	$ 5.16M	$ 7.01M	$ 6.78M	$ 4.81M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -2.85M	$ -5.03M	$ -6.63M	$ -6.01M	$ -1.81M
Total Liabilities	$ 401.94K	$ 1.49M	$ 2.36M	$ 7.30M	$ 7.75M
Stockholders Equity	$ 3.43M	$ 3.67M	$ 4.65M	$ -523.31K	$ -2.94M
Cash Flow	-
Free Cash Flow	$ -2.17M	$ -1.60M	$ -4.93M	$ -2.22M	$ -3.45M
Operating Cash Flow	$ -2.17M	$ -1.60M	$ -4.93M	$ -2.22M	$ -3.45M
Investing Cash Flow	-	-	$ 0.00	$ 1.33K	$ 0.00
Financing Cash Flow	$ 0.00	$ 0.00	$ 5.55M	$ 6.41M	$ -74.60K

Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History

Income Statement >

ImmunoCellular Therapeutics Debt to Assets

Balance Sheet >

ImmunoCellular Therapeutics Cash Flow

Cash Flow >

ImmunoCellular Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing